|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.415 HKD | -6.74% |
|
+29.69% | -58.08% |
CANbridge Pharmaceuticals Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 102.87 million compared to CNY 78.97 million a year ago. Net loss was CNY 378.84 million compared to CNY 483.48 million a year ago.
Basic loss per share from continuing operations was CNY 0.89 compared to CNY 1.14 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -58.08% | 24.15M | |
| +4.06% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +23.46% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
CANBRIDGE PHARMACEUTICALS INC. 
